oxiSperm®II: Evaluation of pro-oxidant activity in semen
Product designed to evaluate pro-oxidant activity in the ejaculate.
What is oxiSperm®II?
oxiSperm®II is an innovative in vitro diagnostic kit designed to revolutionize the analysis of REDOX aspects of the ejaculate during ejaculate quality valuation. This product is based on the capacity of Nitro Blue Tetrazolium (NBT) that becomes reduced by free oxygen radicals (pro-oxidant molecules). This reaction transforms NBT into formazan, which has a purple colour. The intensity of the colour is directly proportional to the pro-oxidant activity of the sample. This end-to-end solution addresses the limitations of conventional semen analysis by evaluating a critical parameter: pro-oxidant activity.
Conventional semen analysis does not consider the assessment of a critical parameter that affects male fertility such as pro-oxidant activity at the ejaculate. oxiSperm®II fills this gap, offering the possibility of determining pro-oxidant activity in neat semen samples, seminal plasma and spermatozoa.
oxiSperm®II is based on the NBT reaction in the form of a pre-assembled and specifically formulated reactive membrane. The interaction of the sample with the reactive membrane results in the appearance of color in the sample, ranging from pale pink to purple/dark blue, which can be easily and comparatively quantified compared to the color palette provided with the kit.
Comprehensive evaluation of pro-oxidant activity: oxiSperm®II allows the evaluation of pro-oxidant activity in neat semen samples, seminal plasma, or spermatozoa in a simple, fast, and reliable way.
Medical professionals use Halotech’s solutions, including oxiSperm®II, to complement conventional semen analysis.
Evaluation of pro-oxidant activity in ejaculation is particularly recommended in several scenarios, including the following:
oxiSperm®II allows medical professionals to comprehensively assess sperm quality by assessing pro-oxidant activity in the ejaculate. By bridging the gap in conventional semen analysis, this innovative diagnostic kit can help optimize treatment decisions and improve reproductive outcomes.